“Mean Percentage Improvement in Psoriasis Area and Severity Index (PASI) Response and Absolute PASI Through 5 Years of Continuous Treatment With Guselkumab (GUS) in VOYAGE 1 ” (2022) SKIN The Journal of Cutaneous Medicine, 6(2), p. s3. doi:10.25251/skin.6.supp.3.